Hydroxychloroquine

The World Health Organization announced Monday that it was pausing an ongoing trial of how hydroxychloroquine impacts hospitalized COVID-19 patients over safety concerns of the anti-malaria drug—medicine that President Donald Trump said he was taking for at least two weeks.A "temporary pause" of the WHO's hydroxychloroquine trial was instituted while "safety data is reviewed," said…

A pharmacy tech pours out pills of hydroxychloroquine at Rock Canyon Pharmacy in Provo, Utah, on May 20, 2020. GEORGE FREY/Getty Images Slate is making its coronavirus coverage free for all readers. Subscribe to support our journalism. Start your free trial. The World Health Organization is pressing pause on its trial of hydroxychloroquine as treatment for…

WHO has praised China for its eagerness towards the prospect of scientific inquiries into determining the origins of COVID-19. The number of coronavirus cases in Russia has climbed to 353,427, with 8,946 new infections in the past 24 hours. The United States has barred arrivals from Brazil, the country with the second-highest number of cases in the…

New Delhi, May 23 A revised government advisory on Friday recommended use of hydroxychloroquine as a preventive medication for asymptomatic healthcare workers working in non-COVID-19 hospitals, frontline staff on surveillance duty in containment zones and paramilitary/police personnel involved in coronavirus infection related activities.  As was mentioned in the earlier advisory, the drug against the infection…

SummaryBackgroundHydroxychloroquine or chloroquine, often in combination with a second-generation macrolide, are being widely used for treatment of COVID-19, despite no conclusive evidence of their benefit. Although generally safe when used for approved indications such as autoimmune disease or malaria, the safety and benefit of these treatment regimens are poorly evaluated in COVID-19.MethodsWe did a multinational…